Impel Wealth Management Moving Life Forward
Social Security Gains Could be Offset
August 30, 2021

This Week from Jesse W. Hurst, II
As much talk and attention as there has been about inflation over the last six months, there is one large group of Americans that stand to benefit from these higher measures of consumer prices, and that is retirees collecting Social Security benefits.
For calendar year 2020, the Social Security COLA adjustment was 1.3%. Since 2010, the largest adjustment was 3.6% in calendar year 2012. In ten of the last twelve years, the inflation adjustment was 2% or less, including three years of 0%.
However, projections from various organizations tracking this data suggests that the COLA for Social Security for calendar year 2022, which are due to be announced on October 13th, could be 6% or higher. This would be the biggest jump since 1982 when benefits rose 7.4%.
This would generally be encouraging for most retirees, to whom Social Security is a major pillar of retirement income. But not so fast. In what could be a cruel twist of fate, Medicare part B premiums and the IRMAA surcharges for calendar year 2022 will be announced in November.
The 2021 increase in Medicare part B premiums was artificially reduced to 25% of the normal amount as part of a Covid relief bill. This left base premiums of $148.50 per Medicare recipient. Without the legislative, premiums would have risen to $160.20 this year. This prior reduction will be added to whatever the normal increase for calendar year 2022 is.
For example, if premiums rose by 5% on a year-over-year basis, premiums for Medicare part B could rise to $168 per person in this example. That would be more than a 13% increase over the 2021 amount. This would likely offset a large portion of the 6%+ Social Security COLA.
If that were not enough to make you somewhat concerned about future medical costs, there is also a growing awareness that new Alzheimer’s drugs being developed, which are very pricey, could add significantly to Medicare’s cost dilemma in the future. One recent drug approval carries an annual price tag per recipient of more than $50,000. If even 20% of the six million Medicare beneficiaries diagnosed with Alzheimer’s received this drug, the cost of this would surpass the spending on all other part B covered drugs combined.
We know that this is not a fun topic to discuss. However, the reality is they are for all of us to deal with. Will Congress intervene with additional relief or by setting limits on new drug reimbursements? We are uncertain. However, it is something we will all need to continue to watch carefully, as we keep “Moving Life Forward”.

Jesse W. Hurst, CFP®, AIF®
Financial Advisor and CEO
Award Recipient Jesse Hurst
The 2021 ranking of the Forbes’ Best–in–State Wealth Advisors1 list was developed by SHOOK Research and is based on in–person and telephone due–diligence meetings to evaluate each advisor qualitatively and on a ranking algorithm that includes client retention, industry experience, review of compliance records, firm nominations, and quantitative criteria (including assets under management and revenue generated for their firms). Overall, approximately 32,725 advisors were considered, and 5,000 (approximately 15.3 percent of candidates) were recognized. The full methodology2 that Forbes developed in partnership with SHOOK Research is available at

1 This recognition and the due–diligence process conducted are not indicative of the advisor's future performance. Your experience may vary. Winners are organized and ranked by state. Some states may have more advisors than others. You are encouraged to conduct your own research to determine if the advisor is right for you. 

2 Portfolio performance is not a criterion due to varying client objectives and lack of audited data. SHOOK does not receive a fee in exchange for rankings. 
Is there something we can help you with? Please call me at 330.800.0182 or email me directly at [email protected].
Consult your financial professional before making any investment decision.
To unsubscribe from the Impel Wealth Management please reply to this e-mail with "Unsubscribe" in the subject line, or write us at 2006 4th Street, Cuyahoga Falls, OH 44221.

Securities and advisory services offered through Cetera Advisors LLC, member FINRA/SIPC, a broker/dealer and a Registered Investment Adviser. Cetera is under separate ownership from any other named entity. Confidential: This email and any files transmitted with it are confidential and are intended solely for the use of the individual or entity to whom this email is addressed. If you are not one of the named recipient(s) or otherwise have reason to believe that you have received this message in error, please notify the sender and delete this message immediately from your computer. Any other use, retention, dissemination, forward, printing, or copying of this message is strictly prohibited. 
Impel Wealth Management | 2006 4th St, Cuyahoga Falls, OH 44221
P: 330.800.0182 • TF: 844.422.5550 • F: 234.312.0460